Keros Therapeutics Statistics
Total Valuation
KROS has a market cap or net worth of $534.07 million. The enterprise value is -$141.97 million.
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KROS has 30.47 million shares outstanding. The number of shares has increased by 17.52% in one year.
| Current Share Class | 30.47M |
| Shares Outstanding | 30.47M |
| Shares Change (YoY) | +17.52% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.46% |
| Owned by Institutions (%) | 78.44% |
| Float | 23.86M |
Valuation Ratios
The trailing PE ratio is 11.13.
| PE Ratio | 11.13 |
| Forward PE | n/a |
| PS Ratio | 2.88 |
| Forward PS | 119.64 |
| PB Ratio | 1.01 |
| P/TBV Ratio | 0.76 |
| P/FCF Ratio | 6.13 |
| P/OCF Ratio | 6.02 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.86, with a Debt / Equity ratio of 0.02.
| Current Ratio | 29.86 |
| Quick Ratio | 29.02 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 0.20 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 10.43% and return on invested capital (ROIC) is 135.82%.
| Return on Equity (ROE) | 10.43% |
| Return on Assets (ROA) | 4.40% |
| Return on Invested Capital (ROIC) | 135.82% |
| Return on Capital Employed (ROCE) | 6.47% |
| Weighted Average Cost of Capital (WACC) | 8.61% |
| Revenue Per Employee | $3.01M |
| Profits Per Employee | $785,963 |
| Employee Count | 82 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, KROS has paid $6.70 million in taxes.
| Income Tax | 6.70M |
| Effective Tax Rate | 9.41% |
Stock Price Statistics
The stock price has increased by +61.42% in the last 52 weeks. The beta is 0.84, so KROS's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +61.42% |
| 50-Day Moving Average | 19.36 |
| 200-Day Moving Average | 15.98 |
| Relative Strength Index (RSI) | 39.82 |
| Average Volume (20 Days) | 288,706 |
Short Selling Information
The latest short interest is 2.35 million, so 7.70% of the outstanding shares have been sold short.
| Short Interest | 2.35M |
| Short Previous Month | 2.48M |
| Short % of Shares Out | 7.70% |
| Short % of Float | 9.83% |
| Short Ratio (days to cover) | 4.65 |
Income Statement
In the last 12 months, KROS had revenue of $246.72 million and earned $64.45 million in profits. Earnings per share was $1.57.
| Revenue | 246.72M |
| Gross Profit | 91.76M |
| Operating Income | 46.49M |
| Pretax Income | 71.15M |
| Net Income | 64.45M |
| EBITDA | 47.93M |
| EBIT | 46.49M |
| Earnings Per Share (EPS) | $1.57 |
Full Income StatementBalance Sheet
The company has $693.47 million in cash and $17.43 million in debt, with a net cash position of $676.04 million or $22.19 per share.
| Cash & Cash Equivalents | 693.47M |
| Total Debt | 17.43M |
| Net Cash | 676.04M |
| Net Cash Per Share | $22.19 |
| Equity (Book Value) | 703.58M |
| Book Value Per Share | 17.32 |
| Working Capital | 695.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $88.79 million and capital expenditures -$1.71 million, giving a free cash flow of $87.08 million.
| Operating Cash Flow | 88.79M |
| Capital Expenditures | -1.71M |
| Free Cash Flow | 87.08M |
| FCF Per Share | $2.86 |
Full Cash Flow StatementMargins
Gross margin is 37.19%, with operating and profit margins of 18.84% and 26.12%.
| Gross Margin | 37.19% |
| Operating Margin | 18.84% |
| Pretax Margin | 28.84% |
| Profit Margin | 26.12% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 18.84% |
| FCF Margin | 35.30% |
Dividends & Yields
KROS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -17.52% |
| Shareholder Yield | -17.52% |
| Earnings Yield | 12.07% |
| FCF Yield | 16.31% |
Analyst Forecast
The average price target for KROS is $23.00, which is 31.20% higher than the current price. The consensus rating is "Buy".
| Price Target | $23.00 |
| Price Target Difference | 31.20% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 80.20% |
| EPS Growth Forecast (5Y) | -14.79% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KROS has an Altman Z-Score of 14.92 and a Piotroski F-Score of 7.
| Altman Z-Score | 14.92 |
| Piotroski F-Score | 7 |
